Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference
May 01, 2018 20:01 pm UTC| Business
WEST LAFAYETTE, Ind., May 01, 2018 -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s management team will...
Big 5 Sporting Goods Corporation Announces Fiscal 2018 First Quarter Results
May 01, 2018 20:01 pm UTC| Business
EL SEGUNDO, Calif., May 01, 2018 -- Big 5 Sporting Goods Corporation (NASDAQ:BGFV) (the “Company”), a leading sporting goods retailer, today reported financial results for the fiscal 2018 first quarter ended April 1,...
May 01, 2018 20:01 pm UTC| Business
MIDLAND, Texas, May 01, 2018 -- Viper Energy Partners LP (NASDAQ:VNOM) ("Viper" or the “Company”), a subsidiary of Diamondback Energy, Inc. (NASDAQ:FANG) ("Diamondback"), today announced financial and operating results...
May 01, 2018 20:01 pm UTC| Business
TAMPA, Fla., May 01, 2018 -- Kforce Inc. (Nasdaq:KFRC), a provider of professional staffing services and solutions, today announced results for its first quarter of 2018. Revenues for the quarter ended March 31, 2018...
May 01, 2018 20:01 pm UTC| Business
– Nhwa granted a license to develop, manufacture, and commercialize oliceridine in China – – Trevena to receive upfront and milestone payments and royalties – CHESTERBROOK, Pa. and XUZHOU, China, May 01, 2018 --...
May 01, 2018 20:01 pm UTC| Business
BURNABY, British Columbia, May 01, 2018 -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2018 financial and operating results...
Retrophin Reports First Quarter 2018 Financial Results
May 01, 2018 20:01 pm UTC| Business
Company obtains FDA and EMA feedback on pathway to NDA and MAA filing for sparsentan in IgA nephropathy; single Phase 3 trial expected to initiate in the fourth quarter of 2018 Pivotal Phase 3 DUPLEX Study of sparsentan...